Dr. Daniel Nader
Pulmonologist and Chief of StaffAffiliated Treatment Facilities
01. Doctor Overview
Doctor Overview
Dr. Nader is a known leader in the treatment of pulmonary diseases in the Oklahoma. As Oklahoma’s representative to the American College of Chest Physicians, he has served in a critical role that involved not only sharing his vast knowledge of pulmonary diseases, but also serving as a patient advocate and lobbying for assistance from government officials. Dr. Nader’s efforts have been rewarded with a seat on the board of directors of the American Association for Bronchology.
For more than two decades, Dr. Nader has helped patients and developed innovative treatments for lung and chest diseases at the Cancer Treatment Centers of America, the only hospital in Oklahoma dedicated exclusively to cancer treatment. Dr. Nader has been part of CTCA since 1992, two years after the facility opened its doors. His areas of expertise include lung cancer, mesothelioma and tumors of the bronchus.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Pulmonology
Other Interests & Specialties: Pulmonology, general pulmonary medicine, interventional pulmonology, thoracic oncology, tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, emphysema and pneumonia.
Certifications, Awards & Accolades: American Board of Pulmonary Disease Certification, American Board of Internal Medicine Certification, America’s Top Doctors, America’s Top Doctors for Cancer, Oklahoma Magazine Top Doctors
Education & Experience:
- Medical Degree from Kansas City University College of Osteopathic Medicine
- Residency for Internal Medicine at Naval Medical Center
- Fellowship for Pulmonary Disease at Naval Medical Center
03. Publications
Publications
Endobronchial valve treatment for prolonged air leaks of the lung: a case series. The Annals of Thoracic Surgery. January 2011;91(1):270-273. doi: 10.1016/j.athoracsur.2010.07.093
Bronchial Valve Treatment of Emphysena: Results and Conclusions from a Double-Blind Randomization Trial in Surgical and Bronchoscopic Lung Volume Reduction: State of the Art Mini Symposium. Journal of Thoracic Disease. April 2018;10(4). doi: 10.21037/jtd.2018.02.72
Resources for Mesothelioma Patients
